Scott Mendel - Net Worth and Insider Trading

Scott Mendel Net Worth

The estimated net worth of Scott Mendel is at least $14 Million dollars as of 2024-04-26. Scott Mendel is the President & CEO of GenMark Diagnostics Inc and owns about 593,519 shares of GenMark Diagnostics Inc (GNMK) stock worth over $14 Million. Scott Mendel is also the Director of Akoya Biosciences Inc and owns about 28,500 shares of Akoya Biosciences Inc (AKYA) stock worth over $108,585. Details can be seen in Scott Mendel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott Mendel has not made any transactions after 2023-06-12 and currently still holds the listed stock(s).

Transaction Summary of Scott Mendel

To

Scott Mendel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott Mendel owns 3 companies in total, including GenMark Diagnostics Inc (GNMK) , Akoya Biosciences Inc (AKYA) , and Quantum-Si Inc (QSI) .

Click here to see the complete history of Scott Mendel’s form 4 insider trades.

Insider Ownership Summary of Scott Mendel

Ticker Comapny Transaction Date Type of Owner
GNMK GenMark Diagnostics Inc 2021-01-25 director & President & CEO
AKYA Akoya Biosciences Inc 2023-06-12 director
QSI Quantum-Si Inc 2023-05-11 director

Scott Mendel Latest Holdings Summary

Scott Mendel currently owns a total of 2 stocks. Among these stocks, Scott Mendel owns 593,519 shares of GenMark Diagnostics Inc (GNMK) as of January 25, 2021, with a value of $14 Million and a weighting of 99.24%. Scott Mendel also owns 28,500 shares of Akoya Biosciences Inc (AKYA) as of June 12, 2023, with a value of $108,585 and a weighting of 0.76%.

Latest Holdings of Scott Mendel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GNMK GenMark Diagnostics Inc 2021-01-25 593,519 24.04 14,268,197
AKYA Akoya Biosciences Inc 2023-06-12 28,500 3.81 108,585

Holding Weightings of Scott Mendel


Scott Mendel Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott Mendel has made a total of 21 transactions in GenMark Diagnostics Inc (GNMK) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in GenMark Diagnostics Inc is the sale of 64,975 shares on January 25, 2021, which brought Scott Mendel around $924,594.

According to the SEC Form 4 filings, Scott Mendel has made a total of 2 transactions in Akoya Biosciences Inc (AKYA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Akoya Biosciences Inc is the acquisition of 20,000 shares on June 12, 2023, which cost Scott Mendel around $100,000.

Insider Trading History of Scott Mendel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott Mendel Trading Performance

GuruFocus tracks the stock performance after each of Scott Mendel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Mendel is -15.71%. GuruFocus also compares Scott Mendel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Mendel within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Scott Mendel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Scott Mendel

Average Return

20.97%

Average return per transaction

Outperforming Transactions

33%

1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.77 -15.71 -25.94 20.97 -10.48 -6.34
Relative Return to S&P 500(%) 14.89 -15.48 -23.77 20.46 -18.05 -18.22

Scott Mendel Ownership Network

Ownership Network List of Scott Mendel

No Data

Ownership Network Relation of Scott Mendel


Scott Mendel Owned Company Details

What does GenMark Diagnostics Inc do?

Who are the key executives at GenMark Diagnostics Inc?

Scott Mendel is the director & President & CEO of GenMark Diagnostics Inc. Other key executives at GenMark Diagnostics Inc include SVP & Engineering and Tech Dev Tyler Jensen , VP & Assay Development Christine Shaw , and VP & Qual & Reg & & Clin Affairs Alan Baer Maderazo .

GenMark Diagnostics Inc (GNMK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GenMark Diagnostics Inc (GNMK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GenMark Diagnostics Inc (GNMK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GenMark Diagnostics Inc (GNMK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GenMark Diagnostics Inc Insider Transactions

No Available Data

Scott Mendel Mailing Address

Above is the net worth, insider trading, and ownership report for Scott Mendel. You might contact Scott Mendel via mailing address: 5964 La Place Court, Address 2, Carlsbad Ca 92008.

Discussions on Scott Mendel

No discussions yet.